PubRank
Search
About
Jonathan Cebon
Author PubWeight™ 1.60
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor.
J Clin Oncol
2014
1.55